Home › Funds › Millennium Management › ESPR
Millennium Management position in ESPR
ESPERION THERAPEUTICS INC NE
Latest position (Q2 2026)2.23M sh
Reported value held$7.03M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 467.30K | $5.63M | New |
| Q4 2021 | 334.43K | $1.67M | Reduce |
| Q1 2022 | 1.25M | $5.79M | Add |
| Q2 2022 | 2.71M | $17.21M | Add |
| Q3 2022 | 1.72M | $11.54M | Reduce |
| Q4 2022 | 2.47M | $15.41K | Add |
| Q1 2023 | 4.18M | $6.64K | Add |
| Q2 2023 | 3.55M | $4.93M | Reduce |
| Q3 2023 | 5.99M | $5.87M | Add |
| Q4 2023 | 3.64M | $10.90M | Reduce |
| Q1 2024 | 5.68M | $15.23M | Add |
| Q2 2024 | 6.81M | $15.13M | Add |
| Q3 2024 | 3.40M | $5.62M | Reduce |
| Q4 2024 | 829.88K | $1.83M | Reduce |
| Q1 2025 | 961.03K | $1.38M | Add |
| Q2 2025 | 452.65K | $445.59K | Reduce |
| Q3 2025 | 974.86K | $2.58M | Add |
| Q4 2025 | 3.93M | $14.55M | Add |
| Q1 2026 | 604.35K | $1.66M | Reduce |
| Q2 2026 | 2.23M | $7.03M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ESPR
- BlackRock Inc 22.13M sh · $69.92M · Q2 2026
- Vanguard Group 14.95M sh · $55.30M · Q4 2025
- Goldman Sachs Group 10.38M sh · $32.80M · Q2 2026
- Two Sigma Investments 7.13M sh · $22.52M · Q2 2026
- Geode Capital Management 6.63M sh · $20.96M · Q2 2026
- Balyasny Asset Management 4.65M sh · $14.71M · Q2 2026
- Fidelity Management & Research (FMR) 4.61M sh · $14.58M · Q2 2026
- UBS Group AG 3.84M sh · $12.12M · Q2 2026
- Northern Trust Corp 2.32M sh · $7.34M · Q2 2026
- Fidelity International (FIL) 2.11M sh · $6.66M · Q2 2026
- JPMorgan Chase & Co 1.40M sh · $4.40M · Q2 2026